Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

April 21, 2023

Study Completion Date

June 21, 2024

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

Fusion closed loop glucose control system

The FUSION system will be used to control the subjects glucose to a range of 100-140 mg/dL. Data will be collected for up to 24 hours, or upon early termination of the study session.

Trial Locations (1)

30322

Emory University, Atlanta

Sponsors
All Listed Sponsors
collaborator

Emory University

OTHER

lead

Ideal Medical Technologies

INDUSTRY

NCT05644730 - Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes | Biotech Hunter | Biotech Hunter